Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04726332 |
|
Recruitment Status :
Terminated
(Business reasons)
First Posted : January 27, 2021
Last Update Posted : May 14, 2024
|
Sponsor:
Exelixis
Information provided by (Responsible Party):
Exelixis
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | May 2, 2024 |
| Actual Study Completion Date : | May 2, 2024 |